WHWK — Whitehawk Therapeutics Share News
0.000.00%
Last trade - 00:00- $183.00m
- -$6.98m
- $7.15m
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX
US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake
U.S. STOCKS ON THE MOVE-WhiteHawk, Mirum Pharmaceuticals, Nvidia
Australia's WhiteHawk gains on entering $1.05 million debt facility
Brief: Whitehawk Therapeutics Appoints Vijay Iyengar, MD, To Board Of Directors
Whitehawk Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Whitehawk Therapeutics Q2 net loss narrows
Whitehawk Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Whitehawk Therapeutics - Files To Offer And Resell Up To 22.32 Million Shares Of Common Stock By Selling Stockholders
Brief: Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing
Natural gas firm WhiteHawk reveals sevenfold revenue surge in US IPO filing (updated)
Whitehawk Therapeutics Q1 net loss beats estimates
Whitehawk Therapeutics reports bigger-than-expected Q4 loss on higher R&D costs
Brief: Whitehawk Therapeutics Advances To Clinical Stage With Ind Clearance For Hwk-007
U.S. RESEARCH ROUNDUP-APi Group, Elf Beauty, Tesla
Brief: Whitehawk Therapeutics Appoints Margaret Dugan, As Chief Medical Officer
Whitehawk Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results And Recent Highlights
Whitehawk Therapeutics Inc expected to post earnings of 49 cents a share - Earnings Preview